Pharmaceutical assessment of low global warming potential alternatives to HFA-134a in a budesonide, glycopyrrolate, and formoterol fumarate pressurized metered-dose inhaler

Kellisa Lachacz, Richard Kaye, Lauren Mello, Ashley Stoker, Johannes Törnell

Open source

DOI
10.1016/j.xphs.2026.104458
Published
2026-10
Container
Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.xphs.2026.104458,
  title = {Pharmaceutical assessment of low global warming potential alternatives to HFA-134a in a budesonide, glycopyrrolate, and formoterol fumarate pressurized metered-dose inhaler},
  author = {Kellisa Lachacz and Richard Kaye and Lauren Mello and Ashley Stoker and Johannes Törnell},
  year = {2026},
  journal = {Journal of Pharmaceutical Sciences},
  doi = {10.1016/j.xphs.2026.104458},
  url = {https://doi.org/10.1016/j.xphs.2026.104458}
}

RIS

TY  - JOUR
TI  - Pharmaceutical assessment of low global warming potential alternatives to HFA-134a in a budesonide, glycopyrrolate, and formoterol fumarate pressurized metered-dose inhaler
AU  - Kellisa Lachacz
AU  - Richard Kaye
AU  - Lauren Mello
AU  - Ashley Stoker
AU  - Johannes Törnell
PY  - 2026
JO  - Journal of Pharmaceutical Sciences
DO  - 10.1016/j.xphs.2026.104458
UR  - https://doi.org/10.1016/j.xphs.2026.104458
ER  - 

APA

Lachacz, K., Kaye, R., Mello, L., Stoker, A., & Törnell, J. (2026). Pharmaceutical assessment of low global warming potential alternatives to HFA-134a in a budesonide, glycopyrrolate, and formoterol fumarate pressurized metered-dose inhaler. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2026.104458

Source records